- Home
- SIGA vs GBAB Comparison
SIGA vs GBAB Comparison
Compare SIGA & GBAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SIGA | GBAB |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.0M | 412.4M |
| IPO Year | 2016 | 2010 |
Fundamental Metrics
Financial Performance| Metric | SIGA | GBAB |
|---|---|---|
| Price | $4.98 | $14.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 636.4K | 90.5K |
| Earning Date | 03-10-2026 | 01-01-0001 |
| Dividend Yield | ★ 12.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $224.81 | N/A |
| P/E Ratio | $15.56 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.81 | $14.20 |
| 52 Week High | $9.62 | $15.94 |
Technical Indicators
Market Signals| Indicator | SIGA | GBAB |
|---|---|---|
| Relative Strength Index (RSI) | 31.62 | 35.06 |
| Support Level | $4.81 | $14.48 |
| Resistance Level | $6.98 | $15.43 |
| Average True Range (ATR) | 0.26 | 0.23 |
| MACD | -0.04 | -0.07 |
| Stochastic Oscillator | 13.70 | 29.27 |
Price Performance
Historical ComparisonAbout SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust of Beneficial Interest
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust is a diversified closed-end management investment company. Its investment objective is to provide current income with a secondary objective of long-term capital appreciation. Its products include Mutual funds, Unit investment trusts, Closed-end funds, Rydex funds, Credit income fund and others.